BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24392116)

  • 1. Comparison of the efficacy and safety of S-1-based and capecitabine-based regimens in gastrointestinal cancer: a meta-analysis.
    Zhang X; Cao C; Zhang Q; Chen Y; Gu D; Shen Y; Gong Y; Chen J; Tang C
    PLoS One; 2014; 9(1):e84230. PubMed ID: 24392116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
    He MM; Wu WJ; Wang F; Wang ZQ; Zhang DS; Luo HY; Qiu MZ; Wang FH; Ren C; Zeng ZL; Xu RH
    PLoS One; 2013; 8(12):e82798. PubMed ID: 24349363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Meta-analysis Reveals S-1-based Chemotherapy Improves the Survival of Patients With Advanced Gastric Cancer.
    Wu FL; Lu DC; Ying YP; Huang JJ; Zhou AM; Jiang DK; Chen MW; Yang X; Zhou J; Huang HQ; Zeng HY
    Medicine (Baltimore); 2015 Apr; 94(16):e652. PubMed ID: 25906091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy and safety of S-1 and capecitabine in patients with metastatic colorectal carcinoma: A systematic review and meta-analysis.
    Chen J; Wang J; Xu T
    Medicine (Baltimore); 2019 Jul; 98(30):e16667. PubMed ID: 31348323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Platinum/S-1 and Platinum/5-Fluorouracil as First-Line Chemotherapy for Advanced Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    Luo D; Wang L; Chen X; Xiong Y; Yi F; Ding J; Ding H; Wei Y; Zhang W
    Chemotherapy; 2020; 65(1-2):11-20. PubMed ID: 32535588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.
    Ter Veer E; Ngai LL; Valkenhoef GV; Mohammad NH; Anderegg MCJ; van Oijen MGH; van Laarhoven HWM
    Sci Rep; 2017 Aug; 7(1):7142. PubMed ID: 28769123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study.
    Kim MJ; Oh DY; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    BMC Cancer; 2008 Dec; 8():374. PubMed ID: 19091129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials.
    Li DH; Pan ZK; Ye F; An HX; Wu JX
    Tumour Biol; 2014 Aug; 35(8):8201-8. PubMed ID: 24850178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial.
    Hong YS; Park YS; Lim HY; Lee J; Kim TW; Kim KP; Kim SY; Baek JY; Kim JH; Lee KW; Chung IJ; Cho SH; Lee KH; Shin SJ; Kang HJ; Shin DB; Jo SJ; Lee JW
    Lancet Oncol; 2012 Nov; 13(11):1125-32. PubMed ID: 23062232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of S-1-based vs. capecitabine-based adjuvant chemotherapy for patients with gastric cancer: a systematic review and meta-analysis.
    Zhang Q; Qian Y; Yin Y
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1791-1804. PubMed ID: 34275019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit from S-1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: a meta-analysis.
    Cao C; Zhang X; Kuang M; Gu D; He M; Chen J; Tang C
    Cancer Sci; 2014 Aug; 105(8):1008-14. PubMed ID: 24974863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-1-Based versus capecitabine-based preoperative chemoradiotherapy in the treatment of locally advanced rectal cancer: a matched-pair analysis.
    Su M; Zhu LC; Wei HP; Luo WH; Lin RF; Zou CL
    PLoS One; 2014; 9(9):e106162. PubMed ID: 25181318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of capecitabine-based versus S-1-based chemotherapy for metastatic or recurrent gastric cancer: a systematic review and meta-analysis of clinical randomized trials.
    Feng Z; Yan P; Hou X; Feng J; He X; Yang K
    Ann Palliat Med; 2020 May; 9(3):883-894. PubMed ID: 32389017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Cancer: a Bayesian Network Meta-Analysis.
    Zhu L; Liu J; Ma S
    Pathol Oncol Res; 2016 Oct; 22(4):853-61. PubMed ID: 27236591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
    Kim GM; Jeung HC; Rha SY; Kim HS; Jung I; Nam BH; Lee KH; Chung HC
    Eur J Cancer; 2012 Mar; 48(4):518-26. PubMed ID: 22243774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of S-1 vs capecitabine for the treatment of gastric cancer: a meta-analysis.
    He AB; Peng XL; Song J; Zhang JX; Dong WG; Luo RF; Tang Y
    World J Gastroenterol; 2015 Apr; 21(14):4358-64. PubMed ID: 25892887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
    Wan Y; Hui H; Wang X; Wu J; Sun S
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.
    Ter Veer E; Mohammad NH; Lodder P; Ngai LL; Samaan M; van Oijen MG; van Laarhoven HW
    Gastric Cancer; 2016 Jul; 19(3):696-712. PubMed ID: 26754295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral fluoropyrimidines (capecitabine or S-1) and cisplatin as first line treatment in elderly patients with advanced gastric cancer: a retrospective study.
    Seol YM; Song MK; Choi YJ; Kim GH; Shin HJ; Song GA; Chung JS; Cho GJ
    Jpn J Clin Oncol; 2009 Jan; 39(1):43-8. PubMed ID: 18997184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Li D; Chen C; Zhou Y; Chen R; Fan X; Bi Z; Li Z; Liu Y
    Medicine (Baltimore); 2015 Sep; 94(35):e1345. PubMed ID: 26334891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.